Multiple Trials Examined for RET-Targeted Therapies in MTC
September 27th 2021A 58-year-old man presented with a solitary nodule on the neck, occasional shortness of breath, and intermittent excessive fatigue. Twelve months after being treated with systemic therapy, symptoms occurred leading the oncologist to discover metastatic disease.
Three Similar Trials Lead to Adverse Event Comparisons for Use in nmCRPC
September 14th 2021Based on 3 clinical trials, suggest that when managing toxicities in patients with non-metastatic castration-resistant prostate cancer, oncologists should look at the delta instead of the absolute numbers.
Yarchoan Compares Lenvatinib and Sorafenib for Child Pugh B and C Hepatocellular Carcinoma
September 13th 2021During a Targeted Oncology Case-Based Roundtable event, Mark Yarchoan, MD, moderates a discussion about a 77-year-old woman with Child Pugh B and C hepatocellular carcinoma.